
NDASA Guidance and U.S. DOT Response to COVID-19
March 3, 2020 5:30 pmCategorised in: DOT, Feature, NDASA Guidance
This post was written by Christine
Categorised in: DOT, Feature, NDASA Guidance
This post was written by Christine
To resolve trouble with course access or inquire about additional services, please call 800-221-4291.
To learn more about Accredited Drug Testing, please visit accrediteddrugtesting.com.